Advertisement
U.S. Markets closed

Cumberland Pharmaceuticals Inc. (CPIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
1.2300+0.0100 (+0.82%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 17.20M
Enterprise Value 21.43M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.46
Price/Book (mrq)0.65
Enterprise Value/Revenue 0.57
Enterprise Value/EBITDA 106.32

Trading Information

Stock Price History

Beta (5Y Monthly) 0.20
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32.3600
52 Week Low 31.1900
50-Day Moving Average 31.3028
200-Day Moving Average 31.6116

Share Statistics

Avg Vol (3 month) 311.88k
Avg Vol (10 day) 321.22k
Shares Outstanding 514.1M
Implied Shares Outstanding 6N/A
Float 87.93M
% Held by Insiders 144.47%
% Held by Institutions 114.87%
Shares Short (Sep 30, 2024) 415.35k
Short Ratio (Sep 30, 2024) 41.12
Short % of Float (Sep 30, 2024) 40.19%
Short % of Shares Outstanding (Sep 30, 2024) 40.11%
Shares Short (prior month Aug 30, 2024) 48.13k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Jul 06, 2007

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -27.46%
Operating Margin (ttm)-10.42%

Management Effectiveness

Return on Assets (ttm)-5.66%
Return on Equity (ttm)-32.99%

Income Statement

Revenue (ttm)37.79M
Revenue Per Share (ttm)2.67
Quarterly Revenue Growth (yoy)-9.60%
Gross Profit (ttm)N/A
EBITDA -2.83M
Net Income Avi to Common (ttm)-10.38M
Diluted EPS (ttm)-0.7200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.34M
Total Cash Per Share (mrq)1.23
Total Debt (mrq)21.57M
Total Debt/Equity (mrq)82.85
Current Ratio (mrq)1.44
Book Value Per Share (mrq)1.87

Cash Flow Statement

Operating Cash Flow (ttm)-715.64k
Levered Free Cash Flow (ttm)5.59M